A longitudinal study of CEACAM1 expression in melanoma disease progression

被引:17
作者
Zippel, Douglas [1 ,2 ]
Barlev, Hani [1 ]
Ortenberg, Rona [3 ]
Barshack, Iris [2 ,4 ]
Schachter, Jacob [2 ,3 ]
Markel, Gal [2 ,3 ,5 ]
机构
[1] Chaim Sheba Med Ctr, Dept Surg C, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
[3] Chaim Sheba Med Ctr, Ella Inst Melanoma, IL-52621 Tel Hashomer, Israel
[4] Chaim Sheba Med Ctr, Inst Pathol, IL-52621 Tel Hashomer, Israel
[5] Chaim Sheba Med Ctr, Talpiot Med Leadership Program, IL-52621 Tel Hashomer, Israel
关键词
CEACAM1; metastatic melanoma; immunotherapy; ELEVATED EXPRESSION; MALIGNANT-MELANOMA; ADHESION; LUNG; INHIBITION; ANTIBODY; PROTEIN; SAFETY; CELLS;
D O I
10.3892/or.2014.3703
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The present study characterized the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) expression profile in a longitudinal study during melanoma progression, in lesions obtained from the same patients: a primary skin lesion, a lymph node and a distant metastasis. The present study is expected to increase our understanding of the expression patterns of CEACAM1 in melanoma development. We identified 20 patients who could be analyzed for CEACAM1 expression over the course of disease progression. The pathology blocks were cut, and two slides were generated for each specimen. One underwent standard hematoxylin and eosin (H&E) staining and a corresponding slide underwent immunohistochemical staining for the detection of CEACAM1. For 13 patients who were able to be followed up serially from primary lesion, lymph node and distant metastasis, a borderline significant increase in the staining of the membrane was noted (P=0.06). In contrast, there was no equivalent increase in cytoplasmic CEACAM1 in the same group of patients. For the cohort of 20 patients with primary and distant metastasis, a significant increase in the membrane staining was noted (P=0.026) and again, no equivalent significant increase in cytoplasmic staining was observed. We report that CEACAM1 expression increases along the course of disease development and progression of a patient. CEACAM1 represents a novel area of research which may have profound influence in future methods of harnessing cellular immunity to combat this disease. The results of the present study confirm that CEACAM1 is potentially an extremely useful target in arresting melanoma progression.
引用
收藏
页码:1314 / 1318
页数:5
相关论文
共 50 条
[41]   Regulation of the Epithelial Adhesion Molecule CEACAM1 Is Important for Palate Formation [J].
Mima, Junko ;
Koshino, Aya ;
Oka, Kyoko ;
Uchida, Hitoshi ;
Hieda, Yohki ;
Nohara, Kanji ;
Kogo, Mikihiko ;
Chai, Yang ;
Sakai, Takayoshi .
PLOS ONE, 2013, 8 (04)
[42]   Soluble CEACAM8 Interacts with CEACAM1 Inhibiting TLR2-Triggered Immune Responses [J].
Singer, Bernhard B. ;
Opp, Lena ;
Heinrich, Annina ;
Schreiber, Frauke ;
Binding-Liermann, Ramona ;
Berrocal-Almanza, Luis Carlos ;
Heyl, Kerstin A. ;
Mueller, Mario M. ;
Weimann, Andreas ;
Zweigner, Janine ;
Slevogt, Hortense .
PLOS ONE, 2014, 9 (04)
[43]   On the Dual Role of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 1 (CEACAM1) in Human Malignancies [J].
Calinescu, Andreea ;
Turcu, Gabriela ;
Nedelcu, Roxana I. ;
Brinzea, Alice ;
Hodorogea, Anastasia ;
Antohe, Mihaela ;
Diaconu, Carmen ;
Bleotu, Coralia ;
Pirici, Daniel ;
Jilaveanu, Lucia B. ;
Ion, Daniela A. ;
Badarau, Ioana A. .
JOURNAL OF IMMUNOLOGY RESEARCH, 2018, 2018
[44]   The different expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) and possible roles in gastric carcinomas [J].
Zhou, Cheng-Jun ;
Liu, Bin ;
Zhu, Kong-Xi ;
Zhang, Qing-Hui ;
Zhang, Ting-Guo ;
Xu, Wei-Hua ;
Wang, Hong-Bo ;
Yu, Wei-Hua ;
Qu, Yun-Dong ;
Wang, Hong-Juan ;
Wu, Hong-Li ;
Sun, Shan-Zhen ;
Guo, Jian-Qiang .
PATHOLOGY RESEARCH AND PRACTICE, 2009, 205 (07) :483-489
[45]   Assessing the Impact of Targeting CEACAM1 in Head and Neck Squamous Cell Carcinoma [J].
Tam, Kenric ;
Schoppy, David W. ;
Shin, June Ho ;
Tay, Joshua K. ;
Moreno-Nieves, Uriel ;
Mundy, David C. ;
Sunwoo, John B. .
OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2018, 159 (01) :76-84
[46]   Roles of CEACAM1 in cell communication and signaling of lung cancer and other diseases [J].
Ling, Ye ;
Wang, Jian ;
Wang, Lingyan ;
Hou, Jiayun ;
Qian, Peiyu ;
Wang Xiang-dong .
CANCER AND METASTASIS REVIEWS, 2015, 34 (02) :347-357
[47]   Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma [J].
Deng, X. ;
Liu, P. ;
Zhao, Y. ;
Wang, Q. .
GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03) :7686-7697
[48]   Aquaporin-1 Protein Expression of the Primary Tumor May Predict Cerebral Progression of Cutaneous Melanoma [J].
Imredi, E. ;
Liszkay, G. ;
Kenessey, I. ;
Plotar, V. ;
Godeny, M. ;
Toth, B. ;
Fedorcsak, I. ;
Timar, Jozsef .
PATHOLOGY & ONCOLOGY RESEARCH, 2020, 26 (01) :405-410
[49]   CEACAM1 on activated NK cells inhibits NKG2D-mediated cytolytic function and signaling [J].
Hosomi, Shuhei ;
Chen, Zhangguo ;
Baker, Kristi ;
Chen, Lanfen ;
Huang, Yu-Hwa ;
Olszak, Torsten ;
Zeissig, Sebastian ;
Wang, Jing H. ;
Mandelboim, Ofer ;
Beauchemin, Nicole ;
Lanier, Lewis L. ;
Blumberg, Richard S. .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2013, 43 (09) :2473-2483
[50]   Engineering a CEACAM1 Variant with the Increased Binding Affinity to TIM-3 Receptor [J].
Hajihassan, Zahra ;
Saray, Mehran Mohammadpour ;
Yaseri, Aysan .
IRANIAN BIOMEDICAL JOURNAL, 2023, 27 (04) :191-198